HOPKINSON CRAIG C. (EVP R&D, Chief Medical Officer) sold 9.5% of their position (9K shares) of ALKERMES PLC. on the open market
Open‑market sale worth $319.6K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/1/2026ACC: 0001520262-26-000065
Officer· EVP R&D, Chief Medical Officer
Since Mar 2026
-9K
Net shares
Net seller
$319.6K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
5K acquired · 14K disposed
Non-Derivative Transactions2
Ordinary Shares
Direct
Shares
+5K
Price / share
$19.34
Trade value
$96.70K
% of position
5.6%
4/1/2026
89.39K→94.39K
Ordinary Shares
Direct
Shares
−9K
Price / share
$35.51
Trade value
$319.60K
% of position
9.5%
4/1/2026
94.39K→85.39K
Total
Net shares
−4K
Net value
-$222.90K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 4/1/2026 | M · Option Exercise | +5K | $19.34 | $96.70K | 5.6% | 89.39K | 94.39K |
| Ordinary Shares Direct | 4/1/2026 | S · Sale | −9K | $35.51 | $319.60K | 9.5% | 94.39K | 85.39K |
| Total | −4K | -$222.90K | ||||||
Derivative Transactions1
Employee Stock Option (Right to Buy)
Direct
Converts to
Ordinary Shares
5K shares
Shares
−5K
Strike price
19.34
Held after
16.36K
Exercisable
—
4/1/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Ordinary Shares5K shares | 4/1/2026 | M · Option Exercise | −5K | 19.34 | — | 16.36K |